• No se han encontrado resultados

Breast Cancer Screening

N/A
N/A
Protected

Academic year: 2023

Share "Breast Cancer Screening "

Copied!
2
0
0

Texto completo

(1)

Preventive Care in Women's Health

At Easy Choice, we value everything you do to deliver quality care to our members – your patients – to make sure they have a positive health-care experience. That’s why we’re asking you to join us in giving your patients optimal care to help improve quality scores!

Easy Choice’s Quality Improvement Program monitors multiple measures that reflect your patients’

experiences and health.

The following measures are used to assess the quality of patient care.

Breast Cancer Screening

Measure: Percentage of women 50–74 years of age who had one or more mammograms to screen for breast cancer any time on or between Oct. 1 two years prior to the measurement year, and Dec. 31 of the measurement year.

This measure evaluates primary screening, not diagnostic screenings.

Schedule mammogram screenings for your patients

Mammograms can help find breast cancer early, when it might be easier to treat. Easy Choice covers the cost of an annual mammogram for women. These guidelines are for women at average risk. A very small number of women might have an increased risk of breast cancer, and need a different screening plan.

(continued on back)

Quality care is a team effort.

Thank you for playing a starring role!

PRO_12294E Internal Approved 03122018

©WellCare 2018 CA8PROFLY12294E_0000

(2)

American Cancer Society guidelines

1

:

• Women ages 40 to 44 should have the choice to start annual breast cancer screening with mammograms (X-rays of the breast).

• Women ages 45 to 54 should get mammograms every year.

• Women 55 and older should get mammograms every two years, or continue yearly screening.

• Screening should continue as long as a woman is in good health and is expected to live at least 10 more years.

• All women should be familiar with the benefits, limitations and potential harm linked to breast cancer screening.

• Make sure

regular preventive appointments and screenings are up to date.

• Reach out to women who are overdue for screening.

Osteoporosis Management in Women Who Have Had a Fracture

Measure: The percentage of women 67–85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test for osteoporosis in the six months after the fracture.

Early detection of bone loss gives your patient a greater chance to prevent and treat osteoporosis.

A bone density test is the only test that can diagnose osteoporosis before a broken bone occurs. This test helps to estimate the density of your bones and your chance of breaking a bone. The National Osteoporosis Foundation recommends a bone density test of the hip and spine by a central DXA machine to diagnose osteoporosis. DXA stands for dual energy X-ray absorptiometry2.

Please refer members for a bone mineral density test within six months of a fracture or start them on osteoporosis

medication therapy.

NOF recommends women have a bone density test if:

• They are age 65 or older

• They break a bone after age 50

• They are of menopausal age with risk factors

• They are a postmenopausal woman younger than 65 with risk factors

1 https://www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines/

american-cancer-society-guidelines-for-the-early-detection-of-cancer.html

2 https://www.nof.org/patients/diagnosis-information/bone-density-examtesting/

Referencias

Documento similar

osteoprotegerin gene of bone mineral density in Chinese postmenopausal

Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of

Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study. Felson DT, Sloutskis

showed greater height, body mass, whole body bone mineral density (BMD) and content (BMC), upper ex- tremities BMC, lower extremities BMC, femoral neck BMD, Ward’s triangle

Wadhwa VK, Weston R, Mistry R, y col.: Long- term changes in bone mineral density and predicted fracture risk in patients receiving androgen-depriva- tion therapy for prostate

Ioannidis JPA, Stavrou I, Trikalinos TA et al (2002) Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women:

This study clarifies the therapeutic effect of three treatments— quinapril, quinapril ⫹ hydro- chlorothiazide (HCTZ), enalapril— on bone remodeling markers, bone mineral density

Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial.. Endocrine